Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included but will usually appear in 24 hrs or less.

Rational Source
Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice. ✅ Go to Publication ✅
Archives of Iranian medicine (Arch Iran Med ) Vol: 19 Issue 3 Pages: 197-203
Pub: 2016 Mar Epub: Authors Cao Y , Pan Q , Cai W , Shen F , Chen GY , Xu LM , Fan JG ,
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅ Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787
Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ ,
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅ Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787
Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ ,
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅ Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787
Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ ,
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅ Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787
Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ ,
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅ Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787
Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ ,
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅ Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787
Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ ,
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. ✅ Go to Publication ✅
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787
Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ ,
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅ Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529
Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L ,
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅ Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529
Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L ,
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. ✅ Go to Publication ✅
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529
Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L ,
Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome In Vivo. ✅ Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 1210
Pub: 2020 Epub: 2020 Aug 31 Authors Li L , Cui H , Li T , Qi J , Chen H , Gao F , Tian X , Mu Y , He R , Lv S , Chu F , Xu B , Wang P , Lei H , Xu H , Wang C ,
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. ✅ Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 223
Pub: 2020 Epub: 2020 Mar 13 Authors Wu M , Yang S , Wang S , Cao Y , Zhao R , Li X , Xing Y , Liu L ,
Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens. ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 24 Issue 24 Pages:
Pub: 2023 Dec 9 Epub: 2023 Dec 9 Authors Wang C , Yang Y , Chen J , Dai X , Xing C , Zhang C , Cao H , Guo X , Hu G , Zhuang Y ,
Microbiome and metabolome analyses reveal significant alterations of gut microbiota and bile acid metabolism in ETEC-challenged weaned piglets by dietary berberine supplementation. ✅ Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1428287
Pub: 2024 Epub: 2024 Jun 25 Authors Nie X , Lu Q , Yin Y , He Z , Bai Y , Zhu C ,
Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats. ✅ Go to Publication ✅
Obesity facts (Obes Facts ) Vol: 9 Issue 6 Pages: 365-378
Pub: 2016 Epub: 2016 Nov 30 Authors Sun H , Wang N , Cang Z , Zhu C , Zhao L , Nie X , Cheng J , Xia F , Zhai H , Lu Y ,
Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease. ✅ Go to Publication ✅
Clinical and translational medicine (Clin Transl Med ) Vol: 10 Issue 4 Pages: e112
Pub: 2020 Aug Epub: 2020 Aug 13 Authors Li S , Wang N , Tan HY , Chueng F , Zhang ZJ , Yuen MF , Feng Y ,
Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice. ✅ Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 107 Issue Pages: 1556-1563
Pub: 2018 Nov Epub: 2018 Sep 5 Authors Shi Y , Hu J , Geng J , Hu T , Wang B , Yan W , Jiang Y , Li J , Liu S ,
A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. ✅ Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 11 Issue Pages: 588079
Pub: 2020 Epub: 2020 Sep 24 Authors Chen H , Zhang F , Zhang J , Zhang X , Guo Y , Yao Q ,
Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition. ✅ Go to Publication ✅
Journal of cellular and molecular medicine (J Cell Mol Med ) Vol: 26 Issue 4 Pages: 1060-1070
Pub: 2022 Feb Epub: 2022 Jan 5 Authors Zhao Y , Huang J , Li T , Zhang S , Wen C , Wang L ,
Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition. ✅ Go to Publication ✅
Journal of cellular and molecular medicine (J Cell Mol Med ) Vol: 26 Issue 4 Pages: 1060-1070
Pub: 2022 Feb Epub: 2022 Jan 5 Authors Zhao Y , Huang J , Li T , Zhang S , Wen C , Wang L ,
Effects of Berberine on Gut Microbiota in Patients with Mild Metabolic Disorders Induced by Olanzapine. ✅ Go to Publication ✅
The American journal of Chinese medicine (Am J Chin Med ) Vol: 49 Issue 8 Pages: 1949-1963
Pub: 2021 Epub: Authors Pu Z , Sun Y , Jiang H , Hou Q , Yan H , Wen H , Li G ,
The Antifungal Effects of Berberine and Its Proposed Mechanism of Action Through CYP51 Inhibition, as Predicted by Molecular Docking and Binding Analysis. ✅ Go to Publication ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 29 Issue 21 Pages:
Pub: 2024 Oct 27 Epub: 2024 Oct 27 Authors Zhang CW , Huang DY , Rajoka MSR , Wu Y , He ZD , Ye L , Wang Y , Song X ,
Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds. ✅ Go to Publication ✅
Journal of translational medicine (J Transl Med ) Vol: 14 Issue 1 Pages: 237
Pub: 2016 Aug 5 Epub: 2016 Aug 5 Authors Li M , Shu X , Xu H , Zhang C , Yang L , Zhang L , Ji G ,
The Impact of Berberine Loaded Selenium Nanoparticles on K. pneumoniae and Candida albicans Antibiotics Resistance Isolates. ✅ Go to Publication ✅
Archives of Razi Institute (Arch Razi Inst ) Vol: 78 Issue 3 Pages: 1005-1015
Pub: 2023 Jun Epub: 2023 Jun 30 Authors Hasan MF , Jawad Kadhim M , Al-Awady MJ ,
Antimicrobial activity of berberine--a constituent of Mahonia aquifolium. ✅
Folia microbiologica (Folia Microbiol (Praha) ) Vol: 47 Issue 4 Pages: 375-8
Pub: 2002 Epub: Authors Cernáková M , Kostálová D ,
The efficacy and underlying mechanisms of berberine in the treatment of recurrent Clostridioides difficile infection. ✅ Go to Publication ✅
International journal of antimicrobial agents (Int J Antimicrob Agents ) Vol: 65 Issue 5 Pages: 107468
Pub: 2025 Feb 20 Epub: 2025 Feb 20 Authors Wang L , Xu T , Wu S , Zhao C , Huang H ,

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)